Cargando…

Current Landscape of Immune Checkpoint Inhibitor Therapy for Hepatocellular Carcinoma

Mostrar otras versiones (1)

The liver maintains a balance between immune tolerance and activation in its role as a filtration system. Chronic inflammation disrupts this immune microenvironment, thereby allowing for the rise and progression of cancer. Hepatocellular carcinoma (HCC) is a liver tumor generally diagnosed in the se...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ruff, Samantha M., Manne, Ashish, Cloyd, Jordan M., Dillhoff, Mary, Ejaz, Aslam, Pawlik, Timothy M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10297531/ https://www.ncbi.nlm.nih.gov/pubmed/37366922 http://dx.doi.org/10.3390/curroncol30060439

Ejemplares similares

Current Landscape of Immune Checkpoint Inhibitor Therapy for Hepatocellular Carcinoma
por: Machairas, Nikolaos, et al.
Publicado: (2022)

Neoadjuvant therapy for pancreatic ductal adenocarcinoma: Opportunities for personalized cancer care
por: Hamad, Ahmad, et al.
Publicado: (2021)

Combined radiotherapy and immune checkpoint inhibition for the treatment of advanced hepatocellular carcinoma
por: Shannon, Alexander H., et al.
Publicado: (2023)

Neoadjuvant Therapy for Resectable and Borderline Resectable Pancreatic Cancer: A Meta-Analysis of Randomized Controlled Trials
por: Cloyd, Jordan M., et al.
Publicado: (2020)

Textbook oncologic outcomes and regionalization among patients undergoing hepatic resection for intrahepatic cholangiocarcinoma
por: Munir, Muhammad M., et al.
Publicado: (2022)

Neoadjuvant treatment strategies for intrahepatic cholangiocarcinoma
por: Akateh, Clifford, et al.
Publicado: (2020)

National Trends in the Use of Neoadjuvant Therapy Before Cancer Surgery in the US From 2004 to 2016
por: Aquina, Christopher T., et al.
Publicado: (2021)

Comparing textbook outcomes among patients undergoing surgery for cancer at U. S. News & World Report ranked hospitals
por: Mehta, Rittal, et al.
Publicado: (2020)

Expert Insights on Current Treatments for Hepatocellular Carcinoma: Clinical and Molecular Approaches and Bottlenecks to Progress
por: Shannon, Alexander H, et al.
Publicado: (2022)

Update on Liver Failure Following Hepatic Resection: Strategies for Prediction and Avoidance of Post-operative Liver Insufficiency
por: Rahnemai-Azar, Amir A., et al.
Publicado: (2017)

Surgical Treatment of Intrahepatic Cholangiocarcinoma: Current and Emerging Principles
por: Beal, Eliza W., et al.
Publicado: (2020)

Stereotactic Body Radiation Therapy (SBRT) Plus Immune Checkpoint Inhibitors (ICI) in Hepatocellular Carcinoma and Cholangiocarcinoma
por: Jiang, Joanna, et al.
Publicado: (2022)

Burnout Assessment Among Surgeons and Surgical Trainees During the COVID-19 Pandemic: A Systematic Review
por: Shaikh, Chanza Fahim, et al.
Publicado: (2022)

Is Cell-Free DNA Testing in Hepatocellular Carcinoma Ready for Prime Time?
por: Jeepalyam, Sravan, et al.
Publicado: (2023)

Current progress and prospect of immune checkpoint inhibitors in hepatocellular carcinoma
por: Zeng, Zhu, et al.
Publicado: (2020)

Immune Checkpoint Inhibitors in Hepatocellular Carcinoma: Current Progresses and Challenges
por: Liu, Hao-Tian, et al.
Publicado: (2021)

Patient Perspectives on Defining Textbook Outcomes Following Major Abdominal Surgery
por: Wiseman, Jason T., et al.
Publicado: (2021)

Advancements in Microwave Ablation Techniques for Managing Pancreatic Lesions
por: Ardeshna, Devarshi R., et al.
Publicado: (2023)

Real-World Use of Immunotherapy for Hepatocellular Carcinoma
por: Sara, Amir, et al.
Publicado: (2023)

Current landscape and future directions of biomarkers for predicting responses to immune checkpoint inhibitors
por: Zhu, Yingming, et al.
Publicado: (2018)

The Current Landscape of Immune Checkpoint Inhibitor Immunotherapy for Primary and Metastatic Brain Tumors
por: Alimonti, Paolo, et al.
Publicado: (2023)

Disparities in access to care among patients with appendiceal or colorectal cancer and peritoneal metastases: A medicare insurance-based study in the United States
por: Aquina, Christopher T., et al.
Publicado: (2022)

Immune Checkpoint Inhibitors in Hepatocellular Carcinoma: Current Status and Novel Perspectives
por: Federico, Piera, et al.
Publicado: (2020)

Current progress of immune checkpoint inhibitors in the treatment of advanced hepatocellular carcinoma
por: Yin, Xiaoqiang, et al.
Publicado: (2022)

Mutational Landscape and Precision Medicine in Hepatocellular Carcinoma
por: Gorji, Leva, et al.
Publicado: (2023)

Characterizing the patient experience during neoadjuvant therapy for pancreatic ductal adenocarcinoma: A qualitative study
por: Stevens, Lena, et al.
Publicado: (2022)

Disparities in Care Access to Liver-Directed Therapy Among Medicare Beneficiaries with Colorectal Cancer Liver Metastasis
por: Aquina, Christopher T., et al.
Publicado: (2022)

The effect of liver disease on hepatic microenvironment and implications for immune therapy
por: Brown, Zachary J., et al.
Publicado: (2023)

Overview of Current Progress in Immune Checkpoint Inhibitor Therapy for Advanced Hepatocellular Carcinoma
por: Dai, Xinlun, et al.
Publicado: (2020)

Immune Checkpoint Inhibitors: The Unexplored Landscape of Geriatric Oncology
por: Choucair, Khalil, et al.
Publicado: (2022)

Current Landscape and Potential Challenges of Immune Checkpoint Inhibitors in Microsatellite Stable Metastatic Colorectal Carcinoma
por: San-Román-Gil, María, et al.
Publicado: (2023)

Telemedicine use by medicare beneficiaries undergoing hepatopancreatic surgery during COVID-19
por: Shaikh, C.F., et al.
Publicado: (2023)

Neoadjuvant and adjuvant treatment strategies for hepatocellular carcinoma
por: Akateh, Clifford, et al.
Publicado: (2019)

Immune Checkpoint Inhibitors in Hepatocellular Carcinoma: An Overview
por: van Doorn, Diederick J., et al.
Publicado: (2020)

Immune Checkpoint Inhibitors for Unresectable Hepatocellular Carcinoma
por: Abd El Aziz, Mohamed A., et al.
Publicado: (2020)

Immune checkpoint inhibitor therapy for hepatocellular carcinoma
por: Ramai, Daryl, et al.
Publicado: (2022)

Advances in immune checkpoint inhibitors for hepatocellular carcinoma
por: Han, Ji Won, et al.
Publicado: (2021)

Immune Checkpoint Inhibitors in Hepatocellular Carcinoma: Current Strategies and Biomarkers Predicting Response and/or Resistance
por: Pelizzaro, Filippo, et al.
Publicado: (2023)

Neoadjuvant chemotherapy for colorectal liver metastases: A contemporary review of the literature
por: Guo, Marissa, et al.
Publicado: (2021)

Cholangiocarcinoma: three different entities based on location
por: Aquina, Christopher T., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_i6uhjasg1qg76du7jmm3gvqusu